Still hungry in week 3 of Mounjaro — is that normal?

Why week 3 is too early to judge whether Mounjaro is working

The decision many people face around week three is whether to wait or to worry. The honest answer is that tirzepatide (the medicine in Mounjaro) works through a gradual build-up, not an overnight switch. Your body is still adjusting to the first four-week pen, and 2.5mg exists specifically to ease that transition. The first pen's job is settling your system, not reshaping your appetite.

Tirzepatide activates two gut-hormone receptors, GIP and GLP-1, both involved in appetite regulation and gastric emptying. That dual action is what makes it the only medicine of its kind licensed for weight management in the UK, but the receptors take time to respond meaningfully. Most people who go on to see significant results still feel broadly normal hunger in the early weeks. The timeline for Mounjaro's effects typically spans weeks, not days. The NHS medicines page for tirzepatide notes that weight loss is expected to take several months of continued use, which gives useful context for why week three hunger is not the measure that matters most.

A question our prescribers hear most weeks: "I don't feel any different, is it even doing anything?" Very often, yes. The changes are subtle at first.

What's actually driving your hunger in week 3

Before concluding the medicine isn't working, it's worth separating appetite from other signals. Mounjaro slows gastric emptying, which means food stays in the stomach longer, but that effect is dose-dependent, and at 2.5mg it may be modest. If you're waking hungry, eating smaller meals and then wanting more within an hour, this is still consistent with early treatment.

Several non-medicine factors are also in play. Sleep deprivation raises ghrelin, the hormone that drives hunger, regardless of what you've taken. High-carbohydrate meals that digest quickly can trigger blood sugar swings that register as hunger even when you have eaten enough. Stress does the same. These are worth addressing in parallel, not instead of treatment, but they explain why two people on identical doses can have completely different experiences in the same week.

If week two felt similar, the experience of still feeling hungry in week 2 follows a very similar pattern, and reading about that progression may help you locate where you are in the arc.

Protein and fibre are worth prioritising at this stage, both slow digestion and help maintain the feeling of fullness. This isn't a diet prescription, just practical sense alongside any appetite medicine.

When ongoing hunger in week 3 might need a clinical conversation

Most of the time, week-three hunger resolves as the dose increases. That's the expected arc. But there are situations where it is worth raising with your prescriber sooner.

If you are finding it genuinely impossible to reduce portion sizes, if hunger is accompanied by nausea, vomiting or other side effects that are making eating erratic, or if you have a history of binge eating or a complicated relationship with food, these are things a prescriber should know about, not because anything is necessarily wrong, but because the treatment plan may need adjusting. The question of whether Mounjaro simply isn't working is worth exploring properly if hunger persists well into higher dose steps.

There is also the practical question of what happens between now and your next pen. If your next delivery falls around a bank holiday or a week when you're travelling, it's worth planning ahead rather than accidentally extending the 2.5mg period. A smooth transition matters more than it might seem.

For a broader picture of how treatment fits together, what to expect in week 3 of Mounjaro covers the wider experience beyond appetite alone, including energy levels and any early side effects.

What comes next, and how the right clinical oversight helps

The decision to continue, adjust or escalate is never yours to make alone on a prescription medicine. That's not a criticism, it's the whole point of clinical review. At 5mg and beyond, most people begin to notice a clearer shift in appetite: meals feel more satisfying, the urge to snack reduces, and food noise (the background preoccupation with eating) quietens. Week three at 2.5mg is not a fair test of that.

NICE's appraisal of tirzepatide, published as TA1026, notes that if there is less than 5% weight loss after six months at the highest tolerated dose, continuing treatment is reviewed. That is the clinical measure, six months at therapeutic doses, not three weeks at the starter dose. You are nowhere near that threshold yet.

If you have questions about how your response compares to what's typical, or whether your dose should be reviewed, the right step is a conversation with your prescriber rather than searching for reassurance online. You can also look at how long it typically takes to stop feeling hungry on Mounjaro for a more detailed timeline. For context on the cost of continuing private treatment as you move through dose steps, the Mounjaro pricing page sets out what to expect.

If you are not yet on treatment and are weighing up your options, speak to our prescribers, a GPhC-registered clinician, not a decision-making algorithm, reads every consultation the same day.